Global Dermatophytic Onychomycosis Market 2016-2020 - Increase in R&D to Develop Drugs with Disease-Modifying Properties

Mar 04, 2016, 16:10 ET from Research and Markets

DUBLIN, March 4, 2016 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/zkk9nl/global) has announced the addition of the "Global Dermatophytic Onychomycosis Market 2016-2020" report to their offering.

The global dermatophytic onychomycosis market is expected to grow at a CAGR of 7.44% during the period 2016-2020.

Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails.

It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.

According to the report, the increase in R&D to develop drugs with disease-modifying properties and a better safety and efficacy profile drives the market. Further, the report states that the side effects associated with dermatophytic onychomycosis drugs are a challenge to the market as they hamper the acceptance of advanced drugs to treat moderate to severe dermatophytic onychomycosis.

Key vendors:

  • Anacor Pharmaceuticals
  • Galderma
  • Janssen Biotech
  • Novartis
  • Valeant Pharmaceuticals

Key questions answered in this report:

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction 

PART 05: Overview: Dermatophytic onychomycosis

PART 06: Pipeline analysis

PART 07: Market landscape 

PART 08: Market segmentation by route of administration

PART 09: Geographical segmentation

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

For more information visit http://www.researchandmarkets.com/research/zkk9nl/global

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com